Abstract
Introduction
Listeria monocytogenes is the main pathogenic species of the respective genus, found both in humans and animals (1, 2) . L. monocytogenes is a Gram-positive rod, capable of growing in conditions such as low temperature, acidic pH, high salt concentration, resistant to the procedures applied in the food industry to inactivate pathogenic microorganisms (3, 4) .
L. monocytogenes is often implicated in human listeriosis, a severe disease which can determine septicemia, meningitis/meningo-encephalitis, abortion and baby illness at birth (5) . Susceptible population groups include the elderly people, immunocompromised individuals, pregnant women and their fetuses or neonates (1) . Consumption of food products contaminated with this microorganism is the main cause of human listeriosis.
Antimicrobial drugs are used routinely to treat listeriosis in humans and animals. For the therapy of listeriosis, the first choice antibiotic treatment is represented by ampicillin or a combination of ampicillin with an aminoglycoside such as gentamycin or streptomycin (6) . In the last years, some studies have reported L. monocytogenes strains that showed multiple drug resistance to different antimicrobial substances, with significance for the public health, therefore requiring a rigorous monitoring of the antimicrobial susceptibility of L. monocytogenes strains (7 -9).
The present study evaluates the susceptibility profiles of 37 L. monocytogenes strains, isolated from animal food products and clinical human samples in Romania, to 15 antibiotics used for the treatment of human and animal bacterial infections.
Materials and methods

Bacterial strains
Out of the total number of 37 L. monocytogenes tested strains, 19 were collected between 2009 and 2013 from various meat and dairy products, including raw minced meat (n=4), pork muscular tissue (n=1), beef muscular tissue (n=1), sausages (n=5), smoked bacon (n=2), bacon in processing (n=1), poultry carcass (n=1), chicken frankfurters (n=1), boiled shell snails (n=1) and cheese products (n=2). The rest of 18 monocytogenes strains were isolated from clinical samples, represented by blood culture (n=7) and cerebrospinal fluid (n=11), from patients with septicemia, meningitis/meningo-encephalitis, abortion and newborns, hospitalized from April 2010 to April 2013 in three medical institutions in Bucharest: Babes Hospital, Elias Hospital, National Institute of Infectious Diseases (INBI) Matei Bals (containing two isolate-pairs, i.e. blood-culture and cerebrospinal fluid, from two patients with sepsis and meningitis/meningo-encephalitis), respecting the ethical issues concerning studies involving human samples. 
Antimicrobial susceptibility testing
The disk diffusion method was used in order to assess the resistance profiles of both the clinical and the food-borne L. monocytogenes strains. The susceptibility testing was performed using a number of 15 antibiotics (Oxoid), with the following concentrations: 10U Penicillin, 10μg Ampicillin, 30μg Amoxicillin/ clavulanic acid, 10μg Imipenem, 30μg Cefuroxime, 30μg Amikacin, 10μg Gentamicin, 30μg Neomycin, 30μg Nalidixic acid, 5μg Ciprofloxacin, 30μg 
Results
This paper reports the antibiotic susceptibility testing of 37 L. monocytogenes strains isolated from foodborne and clinical samples, identified using exclusively phenotypic tests, since molecular taxonomy is not yet implemented in the laboratories performing this study. Apart from penicillin, ampicillin and trimethoprim-sulfamethoxazole, for which clinical breakpoints for Listeria susceptibility testing are defined according to the Clinical and Laboratory Standard Institute (CLSI), in the present study CLSI criteria for staphylococci were used for the interpretation of antibiotic susceptibility results (13) .
All L. monocytogenes food isolates were susceptible to the first choice antibiotic drugs, represented by penicillins ( Table I) . Concerning the antibiotic susceptibility spectrum, the food strains were fully susceptible to penicillin, ampicillin, amoxicillin+clavulanic acid, imipenem, amikacin, gentamicin, chloramphenicol, rifampicin, tetracycline. One of the 19 tested strains was resistant to trimethoprim/sulfamethoxazole. All tested strains proved to be resistant to nalidixic acid and cefuroxime. Six strains were intermediate resistant to ciprofloxacin, one to erythromycin and three to neomycin.
The clinical strains (Table II) proved to be susceptible to aminoglycosides, tetracyclines, chloramphenicol, rifampin and trimethoprim/ sulfamethoxazole. Nine strains proved to be intermediate resistant to ciprofloxacin and one to erythromycin. One isolate-pair (from the blood-culture and cerebrospinal fluid of an im-munocompromised patient with sepsis and meningitis/meningo-encephalitis) proved to be resistant to beta-lactam antibiotics (oxacillin, ampicillin, amoxicillin+clavulanic acid and imipenem) both in disk diffusion method and in E-test (Table III) . Moreover, four strains were resistant to ciprofloxacin, from which one isolate-pair (blood-culture and cerebrospinal fluid) from a 
Discussion
Till present, little is known about the antibiotic resistance profiles of these strains in Romania. The present study, although performed on a small number of strains, is among the first reports on susceptibility profiles of food borne and clinical L. monocytogenes strains isolated in our country. The limited number of clinical strains can be explained by the fact that listeriosis is less common in Romania compared to other European countries, while food isolates of L. monocytogenes are usually unreported, thus making it difficult to gather a large collection of strains. Also, a recent study had shown that out of twenty five samples positive for L. monocytogenes by classical microbiological method, only 22 were confirmed by real-time PCR, suggesting that using only the standard method can lead to false results (14) .
The standard antibiotic therapy for listeriosis is represented by penicillin or ampicillin with gentamicin. For the patients with allergy to penicillin, the treatment may use a combination of vancomycin with an aminoglycoside, as well as cotrimoxazole with rifampin (6, 15, 17, 18) .
All tested L. monocytogenes strains proved to exhibit natural resistance phenotypes to the second and third generation cephalosporins and nalidixic acid, as mentioned by other literature data (7, 16, 19) . Our results are similar to those obtained by Ennaji et al, showing that almost all the analyzed strains (43 strains) of L. monocytogenes were susceptible to a wide range of antibiotics effective against Gram-positive bacteria, belonging to aminoglycosides group and glycopeptides, but were completely resistant to nalidixic acid, colistine, and second and third generations cephalosporins (19) . For this reason, nalidixic acid is incorporated into selective media for the isolation of L. monocytogenes. The high (21) .
The fact that 94.5% L. monocytogenes strains isolated from food products and clinical samples were susceptible to penicillins, the antibiotics commonly used for both veterinary and human listeriosis treatment, suggests that ampicillin or penicillin plus an aminoglycoside could remain the treatment of choice for listeriosis in Romanian patients. However, the fact that two L. monocytogenes strains, isolated from severe infections, showed resistance to different beta-lactam antibiotics, including ampicillin and amoxicillin+clavulanic acid is underlining the need of in vitro antibiotic susceptibility testing of each clinical isolate in order to establish the efficacy of different antibiotics, as well as of extended epidemiological studies to highlight the resistance profiles of L. monocytogenes strains circulating in our country. It has to be taken into account that, although the prevalence of acquired antibiotic resistance in Listeria isolates still remains low, the transferability of the resistance markers proven for Enterococcus faecalis recipient could facilitate further spread in the future. The high susceptibility rate to trimethoprim/sulfamethoxazole (97.2%) indicates that this antibiotic could be used in association with rifampicin as a second-choice therapy in penicillin-allergic patients. The preserved susceptibility of foodborne, clinical, and environmental Listeria isolates to trimethoprim/sulfamethoxazole was confirmed also in a recent, large scale studies, performed on a large number of strains (22, 23) .
